2019•HaematologicaOpen access

Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?

W. Thomas Johnson, Anjali Mishra, Adam Binder, Alejandro A. Gru, Pierluigi Porcu

Abstract

The human T-cell lymphotropic (or leukemia) virus type-1 (HTLV-1) was isolated by Poiesz et al . in 1980 from the T-cell line Hut-102, established from a patient thought to have cutaneous T-cell lymphoma.[1][1] HTLV-1 causes adult T-cell leukemia/lymphoma (ATL), HTLV-1 associated myelopathy/tropical

About this research paper

What this paper is about

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Adult T-cell leukemia/lymphoma, Leukemia, Lymphoma, Medicine, Human T-lymphotropic virus 1, T-cell leukemia, Myelopathy, Oncology